About Charles Irving, Ph.D.
Form D filings for Phythera Therapeutics in 2024 list Charles Irving, Ph.D. as executive officer, director and promoter.
Charles Irving, Ph.D. first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Charles Irving, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Charles Irving, Ph.D. works with at each company, as listed on that company's latest Form D.
Phythera Therapeutics Inc. · Form D, May 16, 2024
NT
Ngoc Tran
Executive officer and promoter
ID
Igor Nasonkin, Ph.D.
Chief Executive Officer and director
HD
Hal Sternberg, Ph.D.
Executive officer, director and promoter
JS
Judith Segall
Executive officer, director and promoter
ZN
Zamira Nasonkin
Promoter